Chris Bardon

Christiana completed her residency in Internal Medicine at the Brigham and Women's Hospital in Boston. She holds an MD, magna cum laude, from Harvard Medical School and an MBA from Harvard Business School. Her undergraduate studies were completed at the Massachusetts Institute of Technology. 

​

Christiana enjoys traveling and working abroad. She is fluent in Chinese, German, and Spanish and proficient in French, Italian, and Portuguese. In her spare time, she enjoys running (Boston Marathon - 3 hours 45 minutes), piano music, and gourmet cooking.

Christiana is the founder and portfolio manager of Burrage Capital. The firm is a hedge fund which invests long and short in biotechnology and medical technology companies. Christiana was previously a biotechnology analyst at Pyramis Global Advisors, a Fidelity Investments subsidiary. At Pyramis, Christiana focused on long and short investing of public biotechnology and medical product companies of all market capitalizations. 

​

Christiana joined Pyramis from MPM Capital, where she was a Principal involved in the diligence, execution and management of both public and private biotechnology investments. While at MPM, she was also the co-Founder and VP of Corporate Development for Cerimon Pharmaceuticals, and worked to help Cerimon secure a $70M Series A Financing.

Christiana is a member of Kauffman Fellows Class 8 and served her fellowship under mentor Ansbert Gadicke at MPM Capital in Munich, Germany.